Gliosarcoma
📧 Sign up to get email alerts when something new happens for Gliosarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-06-12Clinical Trial Update: Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery [Phase 2]
Phase 2 trial evaluating a vaccine therapy with bevacizumab versus bevacizumab alone in patients with surgically resectable recurrent gliobl…
-
CLINICAL_TRIALS trial_result · 2019-04-08Clinical Trial Update: MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]
Phase 2 clinical trial evaluating MRI and PET/FMISO imaging to assess tumor hypoxia in patients with newly diagnosed glioblastoma multiforme…
-
CLINICAL_TRIALS trial_result · 2018-12-28Clinical Trial Update: O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas [Phase 1, Phase 2]
Early-phase trial investigating O6-Benzylguanine–mediated tumor sensitization with chemoprotected autologous stem cell therapy in malignant …
-
CLINICAL_TRIALS trial_result · 2018-10-26Clinical Trial Update: Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma [Phase 2]
Phase 2 trial evaluating bevacizumab and erlotinib after radiation and temozolomide in newly diagnosed glioblastoma multiforme or gliosarcom…
-
CLINICAL_TRIALS trial_result · 2018-07-31Clinical Trial Update: Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme [Phase 2]
Phase 2 trial evaluating aminolevulinic acid (5-ALA) for fluorescence-guided visualization of glioblastoma tumors during surgical resection …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2018-07-19Clinical Trial Update: Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of Glioblastoma [Phase 1]
A Phase 1 clinical trial evaluating a nasal spray for recurrent glioblastoma and related gliomas has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-07-16Clinical Trial Update: DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors [Phase 1]
A Phase 1 trial evaluating DNX-2401 in combination with interferon gamma for recurrent glioblastoma or gliosarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: GW572016 to Treat Recurrent Malignant Brain Tumors [Phase 2]
Phase 2 trial of GW572016 (lapatinib) for recurrent malignant brain tumors has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma [Phase 1, Phase 2]
Phase 1/2 clinical trial assessing plerixafor after radiation therapy and temozolomide in newly diagnosed high-grade glioma has completed wi…
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Radiosurgery Plus Bevacizumab in Glioblastoma [EARLY_Phase 1]
This clinical trial update reports the termination of an early Phase 1 study evaluating radiosurgery in combination with bevacizumab for gli…
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating combinations of sorafenib with erlotinib, tipifarnib, or temsirolimus in adults with recurrent glioblastoma multi…
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases [Phase 1]
This Phase 1 trial assessing bafetinib in adults with recurrent high-grade glioma or brain metastases has completed.
-
CLINICAL_TRIALS trial_result · 2018-02-23Clinical Trial Update: Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma [Phase 1]
A Phase 1 trial evaluating temozolomide with ascorbic acid in recurrent high-grade glioma was terminated; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma [Phase 1]
Phase 1 trial evaluating the combination of plerixafor (AMD3100) and bevacizumab for recurrent high-grade glioma has been terminated. The st…
-
CLINICAL_TRIALS trial_result · 2017-11-09Clinical Trial Update: A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas [Phase 1]
Phase 1 feasibility trial evaluating oral 5-fluorocytosine in combination with genetically modified neural stem cells expressing E. coli cyt…
-
CLINICAL_TRIALS trial_result · 2017-08-16Clinical Trial Update: GDC-0449 in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery [Phase 2]
Phase 2 trial of vismodegib (GDC-0449) in patients with recurrent glioblastoma multiforme that could be surgically removed; the study is com…
-
CLINICAL_TRIALS trial_result · 2017-08-08Clinical Trial Update: Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma [Phase 2]
Phase 2 trial update for dovitinib in adults with recurrent or progressive glioblastoma. The study is completed, with results posted in 2017…
-
CLINICAL_TRIALS trial_result · 2017-08-07Clinical Trial Update: p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors [Phase 1]
This Phase 1 trial tests the safety of the p28 peptide in younger patients with recurrent or progressive central nervous system tumors and t…
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating erlotinib in adults with recurrent malignant glioma or recurrent/progressive meningioma; the study is co…
-
CLINICAL_TRIALS trial_result · 2017-07-12Clinical Trial Update: Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme [Phase 2]
Phase 2 clinical trial evaluating gossypol for progressive or recurrent glioblastoma multiforme; results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme [Phase 2]
Phase 2 trial of cilengitide in adults undergoing surgery for recurrent or progressive glioblastoma multiforme was terminated and results we…
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma [Phase 2]
Phase 2 trial of bendamustine hydrochloride in adults with recurrent or progressive anaplastic glioma has completed and results have been po…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas [Phase 1, Phase 2]
Results from a Phase I/II trial of BMS-247550 for recurrent high-grade gliomas have been posted, evaluating adults with anaplastic astrocyto…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma [Phase 2]
Phase 2 trial of RO4929097, a gamma-secretase/Notch pathway inhibitor, in recurrent or progressive glioblastoma was terminated. Results were…
-
CLINICAL_TRIALS trial_result · 2017-04-17Clinical Trial Update: 3T MRI Biomarkers of Glioma Treatment Response [EARLY_Phase 1]
An early-phase 1 trial evaluating 3T MRI biomarkers for glioma treatment response, sponsored by Vanderbilt-Ingram Cancer Center, has been te…